Medication compliance of children with epilepsy: a cross-sectional survey

Shanshan Wang1, Xu Zhang1, Yongqian Wang1

  • 1Department of Neurology, Children's Hospital of Nanjing Medical University, No. 72, Guangzhou Road, Gulou District, Nanjing, Jiangsu Province, China.

PubMed

Insights

Medication compliance in children with epilepsy is often poor, affecting prognosis. Factors like age, epilepsy duration, parental education, income, and number of drugs influence compliance, requiring targeted interventions.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacy
  • Public Health

Background:

  • Medication compliance is crucial for the long-term health outcomes of children with epilepsy.
  • Poor adherence can significantly worsen the prognosis and quality of life for pediatric patients.

Purpose of the Study:

  • To assess the current status of medication compliance among children with epilepsy.
  • To identify key factors influencing medication adherence in this population.
  • To inform clinical nursing practices for improving pediatric epilepsy management.

Main Methods:

  • A study involving 156 children with epilepsy admitted to a children's hospital.
  • Utilized self-designed questionnaires and a medication compliance scale.
  • Employed Pearson correlation and multivariate logistic regression analyses to identify influencing factors.

Main Results:

  • 37.18% of children exhibited poor medication compliance.
  • Significant correlations found between compliance and age, epilepsy duration, parental education, income, and number of medications.
  • Younger age, longer epilepsy duration, lower parental education, lower income, and polypharmacy were associated with poor compliance.

Conclusions:

  • Medication compliance in children with epilepsy requires improvement.
  • Key influencing factors include patient age, epilepsy duration, socioeconomic status, and treatment complexity.
  • Targeted nursing interventions addressing these factors are essential for enhancing medication adherence.
Abstract

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
192
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
317
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
188
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
376
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
417